Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Atadjan Khamraev

14 ta ish

Ministry of Health, Nukus, Uzbekistan

  1. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    James M. Trauer, Jay Achar, Nargiza Parpieva +7

    MaqolaTuberculosis Research and EpidemiologyBMC Medicine20163 iqtibos
    ABI

  2. Health system support and health system strengthening: two key facilitators to the implementation of ambulatory tuberculosis treatment in Uzbekistan

    Stefan Köhler, Damin Asadov, Andreas Bründer +4

    MaqolaTuberculosis Research and EpidemiologyHealth Economics Review20162 iqtibos
    ABI

  3. Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms

    Stefan Köhler, Damin Asadov, Andreas Bründer +4

    MaqolaHIV/AIDS Impact and ResponsesThe International Journal of Tuberculosis and Lung Disease20142 iqtibos
    ABI

  4. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?

    Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

    BoshqaTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine20151 iqtibos
    ABI

  5. CLINIC, DIAGNOSIS AND EFFICIENCY OF NONINVASIVE METHOD OF TREATMENT YOUNG CHILDREN WITH HAEMORRHOIDS

    Atadjan Khamraev, F. S. Fayzullaev

    MaqolaAnorectal Disease Treatments and OutcomesNeonatology surgery and perinatal medicine20241 iqtibos
    ABI

  6. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

    Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

    MaqolaTuberculosis Research and EpidemiologyERJ Open Research20201 iqtibos
    ABI

  7. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study

    M. Bonnet, Mathieu Bastard, Philipp du Cros +9

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20150 iqtibos
    ABI

  8. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

    Jay Achar, Catherine Berry, Krzysztof Herboczek +7

    BoshqaTuberculosis Research and EpidemiologyEmerging infectious diseases20150 iqtibos
    ABI

  9. Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?

    Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

    BoshqaTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine20150 iqtibos
    ABI

  10. Early cardiac safety of the 9-11 month Short course regimen for MDR-TB treatment

    Catherine Berry, James McMahon, Bern-Thomas Nyang’wa +5

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Infectious Diseases20160 iqtibos
    ABI

  11. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

    Mathieu Bastard, Elisabeth Sánchez-Padilla, Philipp du Cros +12

    MaqolaTuberculosis Research and EpidemiologyPLoS ONE20180 iqtibos
    ABI

  12. HEMORRHOIDS IN CHILDREN

    Atadjan Khamraev, Sh. Juraev, D. Akmollaev

    MaqolaAnorectal Disease Treatments and OutcomesTavricheskiy Mediko-Biologicheskiy Vestnik20220 iqtibos
    ABI

  13. RESULTS OF SURGICAL CORRECTION OF POSTOPERATIVE COMPLICATIONS IN ANORECTAL MALFORMATION IN CHILDREN

    Atadjan Khamraev, D. B. Rakhmonov, У А Хамроев

    MaqolaCongenital gastrointestinal and neural anomaliesNeonatology surgery and perinatal medicine20230 iqtibos
    ABI

  14. Role of ethnicity and residency in active tuberculosis in Karakalpakstan: study protocol of a matched case-control study

    Damin Asadov, Timur Aripov, Sevak Alaverdyan +4

    MaqolaTuberculosis Research and EpidemiologyBMJ Open Respiratory Research20240 iqtibos
    ABI